Keyphrases
Polymorphism
100%
Hearing Impairment
100%
Survivors
100%
Receptor 2
100%
Toll-like
100%
Bacterial Meningitis
100%
Single nucleotide Polymorphism
85%
Meningococcal Meningitis
85%
Toll-like Receptor 4 (TLR4)
57%
Immune-related Genes
42%
Toll-like Receptor 9 (TLR9)
42%
Mutant Alleles
42%
Toll-like Receptor 2 (TLR2)
28%
Immune Response
28%
Meningitis
28%
Pneumococcal Meningitis
28%
Clinical Features
14%
Neuronal Damage
14%
Clinical Characteristics
14%
Genetic Variation
14%
Multiple Testing
14%
Innate Immune Response
14%
Therapeutic Intervention
14%
Clinical High Risk
14%
Disease Manifestations
14%
Genetic Markers
14%
Clinical Severity
14%
Pathogen Recognition
14%
NOD1
14%
NOD2
14%
New Therapeutics
14%
Gene Analysis
14%
Prediction Rule
14%
Genotype Distribution
14%
Cochlear Inflammation
14%
Multiple Pathogens
14%
Caspase-1
14%
Clinical Outcomes
14%
Childhood Bacterial Meningitis
14%
INIS
receptors
100%
losses
100%
nucleotides
100%
hearings
100%
genes
66%
patients
50%
risks
50%
mutants
50%
genetics
33%
testing
16%
diseases
16%
damage
16%
comparative evaluations
16%
variations
16%
interventions
16%
genotype
16%
inflammation
16%
corrections
16%
prediction
16%
distribution
16%
pathogens
16%
Pharmacology, Toxicology and Pharmaceutical Science
Hearing Impairment
100%
Toll Like Receptor 9
100%
Toll Like Receptor 2
100%
Toll Like Receptor 4
100%
Bacterial Meningitis
100%
Epidemic Meningitis
75%
Meningitis
25%
Pneumococcal Meningitis
25%
Inflammation
12%
Disease
12%
Infection
12%
Clinical Feature
12%
Infectious Agent
12%
Neuroscience
TLR 2
100%
TLR 4
100%
Meningitis
100%
TLR9
100%
Single-Nucleotide Polymorphism
33%
Immune Response Gene
16%
Genetic Variation
5%
Individual Differences
5%
Cochlea
5%
Antigen Antibody Complex
5%
Genetic Marker
5%